NCT05206721

Brief Summary

Background: Standard practice of flushing saline over the patient's secretions following suctioning is similar to pouring water over grease, leading to motivating bacterial colonization and proliferation inside the suctioning circuit (i.e., catheter, tube, and collecting jar), which can then migrate to patient's lung during suctioning procedure causing ventilator-associated pneumonia (VAP). Therefore, flushing this circuit using an appropriate disinfectant to prevent bacterial colonization inside it and thus decreasing pneumonia occurrence has been our crucial investigation idea. Aim: To investigate the effect of suction system flushing with chlorhexidine (CHX) on the occurrence of VAP among mechanically ventilated patients (MVPs). Design: This study adopted a quasi-experimental research design, and a convenience sampling technique was used to recruit 136 patients to conduct this study. Setting: This study was conducted at surgical intensive care units of Mansoura University Emergency Hospital, Egypt. Results: The intervention group patients had a lower incidence of VAP (by 48.12%) compared with the control group. Moreover, the proposed technique was more effective in decreasing the incidence of late-VAP more than early-VAP. Furthermore, CHX reduced the cost of suction system flushing by 75%. Conclusion: Suction system flushing with CHX can significantly reduce the occurrence of VAP among MVPs and reduce the flushing cost. Therefore, this study recommends incorporating CHX into the daily care of MVPs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started May 2020

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2020

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 19, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 11, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 25, 2022

Completed
Last Updated

January 25, 2022

Status Verified

January 1, 2022

Enrollment Period

25 days

First QC Date

January 11, 2022

Last Update Submit

January 24, 2022

Conditions

Keywords

ChlorhexidineEndotracheal suctioningAirway managmentsuction circuit flushing

Outcome Measures

Primary Outcomes (1)

  • VAP Incidence

    Occurrence of Ventilator Associated Pneumonia

    an average of 7 months

Study Arms (2)

Intervention group

EXPERIMENTAL
Other: Open tracheal suction system flushing with chlorhexidine

Control group

NO INTERVENTION

Interventions

After suctioning the patient's secretions, the responsible nurse inserted the SC into the CHX filled container and flushed the entire suction system with CHX.

Intervention group

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All adult patients admitted to the afore-mentioned ICUs who were intubated within the previous 24 hours and were expected to receive MV support for more than 48 hours were recruited in the study.

You may not qualify if:

  • Patients with a clinical diagnosis of pneumonia at the time of admission and/or modified CPIS of 5 or greater.
  • Patients who were previously intubated during the current hospital admission.
  • Patients who had contraindications to suctioning such as severe hemoptysis, increased intracranial pressure, and cerebrospinal fluid leaks.
  • Patients with pulmonary edema, ARDS, and those with atelectasis were also excluded from the study because of their pulmonary infiltrate disease pathophysiology.
  • Patients known to be allergic to CHX were also eliminated from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Nursing

Al Mansurah, Dakahlia Governorate, 35516, Egypt

Location

Related Publications (1)

  • Eid MH, Tantu MM, Latour JM, Sultan MA, Kandeel NA. Suction circuit flushing with chlorhexidine decreases ventilator-associated pneumonia: a quasi-experimental study. Front Med (Lausanne). 2023 Dec 4;10:1295277. doi: 10.3389/fmed.2023.1295277. eCollection 2023.

MeSH Terms

Conditions

Pneumonia, Ventilator-Associated

Interventions

Chlorhexidine

Condition Hierarchy (Ancestors)

Healthcare-Associated PneumoniaCross InfectionInfectionsPneumoniaRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic Chemicals

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

January 11, 2022

First Posted

January 25, 2022

Study Start

May 10, 2020

Primary Completion

June 4, 2020

Study Completion

November 19, 2020

Last Updated

January 25, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations